The symptoms of depression in endocrine disorders

CNS Spectrums

Volumn 4, Issue 4, 1999, Pages 51-61

  Hutto, Burton ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; BRADYCARDIA; CLINICAL FEATURE; CUSHING SYNDROME; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRY SKIN; EDEMA; ENDOCRINE DISEASE; HUMAN; HYPERCORTISOLISM; HYPOPITUITARISM; HYPOTHYROIDISM; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; STRESS; SYMPTOMATOLOGY;

EID: 0032894392     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290001155X     Document Type: Review

References (60)

1. Freud S. The resistances to psychoanalysis. In: Strachey J, ed. The Complete Psychological Works of Sigmund Freud. Vol 19. London, England: Hogarth Press; 1923:214-215.
2. Logotheis J. Psychiatric behavior as the initial indicator of adult myxedema. J Nerv Ment Dis. 1963;136:561.
3. Fava M, Labbate LA, Abraham ME, Rosenbaum JF. Hypothyroidism and hyperthyroidism in major depression revisited. J Clin Psychiatry. 1995;56:186-192.
4. Szabadi E. Thyroid dysfunction and affective illness: check the hypothalamic-pituitary-thyroid axes in patients resistant to treatment. BrMedJ. 1991;302:923-924.
5. Denicoff KD, Joffe RT, Lakshmanan MC, Robbins J, Rubinow DR. Neuropsychiatrie manifestations of altered thyroid state. Am J Psychiatry. 1990;147:94-99.
6. Extein IL, Gold MS. Thyroid hormone potentiation of tricyclics. Psychosomatics. 1988;29:166-174.
7. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7:481-492.
8. Sternbach HA, Gold MS, Pottash AC, Extein I. Thyroid failure and protirelin (thyrotropin-releasing hormone) test abnormalities in depressed outpatients. JAMA. 1983;249:1618-1620.
9. Joffe RT, Levitt AJ. Major depression and subclinical (grade 2) hypolhyroidism. Psychoneuroendocrinology. 1992;17:215-221.
10. Haggerty JJ Jr, Marquardt M, McAllister N, Ilgen E, Mason G, Prange AJ. Depressive symptomatology in medical patients with antithyroid antibodies. Biol Psychiatry. 1991;29:153A.
11. Haggerty JJ Jr, Stem RA, Mason G, Beckwith J, Morey CE, Prange AJ. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry. 1993;150:508-510.
12. Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive features in subelinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:925-935.
13. Haggerty J, Suva SG, Marquardt ME, et al. Prevalence of antithyroid antibodies in mood disorders. Depress Anxiety. 1997;5:91-96.
14. Lazarus J, Hall R, Othman S, et al. The clinical spectrum of postpartum thyroid disease. QJM. 1996;89: 429-135.
15. Ball S. Antenatal screening of thyroid antibodies. Lancet. 1996;348:906-907.
16. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease, Horm Res. 1993;39:202-206.
17. Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves' disease. Gen Hasp Psychiatry. 1988;10:49-55.
18. Harris T, Creed F, Brugha TS. Stressful life events and Graves' disease. Br J Psychiatry. 1992;161:535-541.
19. Ehnnann DA, Weinberg M, Same DH. Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch Intern Med. 1989;149:369-372.
20. Roca RP, Blackman MR, Ackerley MB, Harman SM, Gregerman RI. Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocr Res. 1990;16: 415-447.
21. Rose RM. Psychoendocrinology. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 7th ed. Philadelphia, Pa: WB Saunders; 1985:653-681.
22. Kelly WF, Kelly MJ, Faragher B. A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol. 1996;45:715-720.
23. Sonino N, Fava GA. Psychosomatic aspects of Cushing's disease. Psychother Psychosom. 1998;67:140-146.
24. Kelly WF. Psychiatic aspects of Cushing's syndrome. QJM. 1996;89:543-551.
25. Yanovski JA, Cutler GB Jr. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am. 1994;23:489-509.
26. Ross EJ, Linch DC. Cushing's syndrome-killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet. 1982;2:646-649.
27. Pies R. Differential diagnosis and treatment of steroidinduced affective syndromes. Gen Hasp Psychiatry. 1995;17:353-361.
28. Nieman LK, Loriaux DL. Corticotropin-releasing hormone: clinical applications. Annu Rev Med. 1989;40:331-339.
29. Sonino N, Fava GA, Boscaro M. A role for life events in the pathogenesis of Cushing's disease. Clin Endocrinol. 1993;38:261-264.
30. Gotch PM. Cushing's syndrome from the patient's perspective. Endocrinol Metab Clin North Am. 1994;23:607-617.
31. Dom LD, Burgess ES, Dubbert B, et al. Psychopathology in patients with endogenous Cushing's syndrome: 'atypical' or melancholic features. Clin Endocrinol. 1995;43:433-442.
32. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopalhology in Cushing's syndrome after correction of hypercortisolism. / Clin Endocrinol Metab. 1997;82:912-919.
33. Johnstone PA, Rundell JR, Esposito M. Mental status changes of Addison's disease. Psychosomatic!. 1990;31:103-107.
34. Chan AK, Quan-Yang D, Katz M, Siperstein AE, Clark OH. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. Ann Surg. 1995;222:402-414.
35. Okamoto T, Gerstein HC, Obara T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. EndocrJ. 1997;44:367-374.
36. VanPeenen HJ. Depression and hypercalcemia. Am' J Med. 1996;101:111-117.
37. Ozatung S, Guscott RG, Soni J, Steiner M. Psychosis resulting in suicide in a patient with primary hyperthyroidism. Can J Psychiatry. 1986:31:342-343.
38. St. Goar W. Gastrointestinal symptoms as a clue to the diagnosis of primary hyperparathyroidism: a review of 45 cases. Ann Intern Med. 1956;46:102.
39. Leigh H, Kramer SI. The psychiatric manifestations of endocrine disease. Adv Intern Med. 1984:29:413-445.
40. Lawlor BA. Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome. J Clin Psychiatry. 1988;49:317-318.
41. Eaton W, Armenian H, Gallo J, Prall L, Ford DE. Depression and risk for onset of type II diabetes. Diabetes Care. 1996;19:1097-1102.
42. Lustman PJ, Griffin LS, Freedlam! KE, Clouse RE. The course of majpr depression in diabetes. Gen Hasp Psychiatry. 1997;19:138-143.
43. Kohen D, Burgess AP, Catalan J, Lant A. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res. 1998;7:197-204.
44. Jacobson AM. The psychological care of patients with insulin-dependent diabetes mellitus. A' Engl J Med. 1996;334:1249-1253.
45. Goodnick PJ, Henry JH, Buki VMV. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry. 1995;56:128-136.
46. Seidman Si\, Rabkin JG. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord. 1998;48:157-161.
47. Bemesderfer S. A revised psychoanalytic view of menopause. / Am Psychoanal Assoc. 1996;44(suppl):351-369.
48. Nicol-Smith L. Causality, menopause, and depression: a critical review of the literature. BMJ. 1996;313: 1229-1232.
49. Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Er J Psychiatry. 1995:167:163-173.
50. Pearlstein TB. Hormones and depression: what are the facts about premenstrual syndrome menopause and hormone replacement therapy? Am J Obstet Gynecol. 1995;173:646-653 .
51. Hunter MS. Depression and the menopause: depression in a middle aged woman should not automatically be blamed on the menopause. BMJ. 1996;313: 1217-1218.
52. Abed RT, Clark J, Elbadawy MH, Cliffe MJ. Psychiatric morbidity in acromegaly. Acta Psychiatr Scand. 1987;75:635-639.
53. Furman K, Ezzat S. Psychological features of acromegaly. Psycholher Psychosom. 1998;67:147-153.
54. Kellner R, Buckman MT, Fava GA, et al. Hyperprolactinemia distress and hostility. Am J Psychiatry. 19Sl;141:759-763.
55. Koppelman MCS, Parry BL, Hamilton JA, Alagna SW, Loriaux L. Effect of bromocriptine on affect and libido in hyperprolactinemia. Am J Psychiatry. 1987;144: 1037-1041.
56. Rothchild E. Psychologic aspects of galactorrhea. J Psychosom Obstet Gynaecol. 1985;4:185-196.
57. Reavley S, Fisher AD, Owen D, Creed FH, Davis JRE. Psychological distress in patients with hyperprolactinaemia. Clin Endocrinol. 1997;47:343-348.
58. Sobrinho LG, Nunes MCP, Calhaz-Jorge C, Afonso AM, Pereira MC, Santos MA. Hyperprolactinemia in women with paternal deprivation during childhood. Obstet Gynecol. 1984;64:465-468.
59. Sobrinho LG. Emotional aspects of hyperprolactinemia. Psychother Psychosom. 1998;67:133-139.
60. Lynch S, Merson S, Beshyah SA, et al. Psychiatric morbidity in adults with hypopituitarism. J R Soc Med. 1994;87:445-447.